ORAGENICS INC — Director's Dealing 2020

Feb 7, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ORAGENICS INC (OGEN)
CIK: 0001174940
Period of Report: 2020-02-05

Reporting Person: Sullivan Michael O'Keefe (CFO, Secretary and Treasurer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-02-05	Employee Stock Option (Right to Buy)	$0.48	A	250000	Acquired	2030-02-05	Common Stock (250000)	Direct
2020-02-05	Employee Stock Option (Right to Buy)	$0.48	A	250000	Acquired	2030-02-05	Common Stock (250000)	Direct

Footnotes

F1: Represents an annual grant of award of options to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan, as amended (the "Plan") that vests immediately.

F2: Represents a retention grant of award of options to purchase shares of the Company's common stock under the Company's Plan that vest evenly in three tranches. One third of the options vest on the first anniversary of the grant date, the second third of the options vest on the second anniversary of the grant date and the final third vest t on the third anniversary of the grant date. The option exercise price is the closing price on the date of the grant, February 5, 2020.